Replimune Group REPL Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Replimune Group's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Replimune Group's cash & equivalents?
- Replimune Group (REPL) reported cash & equivalents of $124.66M in Q4 2025.
- How has Replimune Group's cash & equivalents changed year-over-year?
- Replimune Group's cash & equivalents decreased by 28.3% year-over-year, from $173.95M to $124.66M.
- What is the long-term trend for Replimune Group's cash & equivalents?
- Over 4 years (2021 to 2025), Replimune Group's cash & equivalents has grown at a -11.5% compound annual growth rate (CAGR), from $184.15M to $112.82M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.